Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Renal Insufficiency × melflufen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 5 Renal Insufficiency 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

Dexamethasone 13 Bortezomib 8 Cyclophosphamide 6 Lenalidomide 5 pomalidomide 3 isatuximab 3 Kidney Transplantation 3 Calcium Dobesilate 3 glucarpidase 2 Thalidomide 2 Gemcitabine 2 Blood Specimen Collection 2 Bendamustine Hydrochloride 2 Azacitidine 2 vinflunine 1 trifluridine tipiracil drug combination 1 trebananib 1 safinamide 1 sacubitril and valsartan sodium hydrate drug combination 1 rubitecan 1 ripretinib 1 regorafenib 1 pevonedistat 1 pembrolizumab 1 mirabegron 1 melflufen 1 gamma-Glutamyl Hydrolase 1 gallium 68 PSMA-11 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03639610 2023-03-10

BRIDGE

Oncopeptides AB

Phase 2 Terminated

35 enrolled 33 charts

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡